26/11/2015 19:39:15 Free Membership Login

Alliance Pharma Company Financial Information

 Company name: Alliance Pharma
 EPIC: APH Trading Currency: GBX
 Market Sector: AIM ISIN: GB0031030819
 Market Segment: AIM Share Type: DE
 WWW Address:  Description: ORD 1P
 Price Price Change [%] Bid Ask Open High Low Volume
 45.75 mages.advfn.com/imagesnew/2/us/down -5.25 [-10.29] 45.00 46.50 45.00 46.50 44.13 840,706
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 120.87 264.20 -0.07 3.17 1.00 14.43 2.19 61.13 - 31.88

Alliance Pharma Key Figures

(at previous day's close)
Market Cap.120.87m
Shares In Issue264.20m
Prev. Close51.00
PE Ratio14.43 
Dividend Yield2.19%
EPS - basic3.17p
Dividend PS1.00p
Dividend Cover3.17 
Cash Flow PS4.32p
Return On Equity (ROE)11.85%
Operating Margin23.33%
PEG Factor-0.85 
EPS Growth Rate-17.02%
Dividends PS Growth Rate9.89%
Net Debt35.65m
Gross Gearing34.38%
Quick Assets11.41m
Net Working Capital5.91m
Intangibles / Fixed Assets98.16%
Turnover PS16.48p
Pre-Tax Profit PS3.84p
Retained Profit PS2.27p
Cash PS0.54p
Net Cash PS-3.78p
Net Tangible Asset Value PS *-6.85p
Net Asset Value PS26.79p
Spread1.50 (3.23%) 

Alliance Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week53.7544.13
4 weeks55.0044.13
12 weeks58.2544.13
1 year61.1331.88

Share Price Chart (5 years)

Alliance Pharma Historic Returns

Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week53.75-8.00-14.8851.700.1551.48
4 weeks53.50-7.75-14.4953.490.0752.82
12 weeks56.00-10.25-18.3055.100.2255.98
26 weeks41.504.2510.2451.400.2952.75
1 year32.0013.7542.9744.350.2247.71
3 years31.3814.3845.8237.550.2438.41
5 years32.0013.7542.9734.490.2634.68

Alliance Pharma Key Management Ratios

Alliance Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio55.14 
PE Ratio14.43 
Tobin's Q Ratio 1.13 
Tobin's Q Ratio (excl. intangibles)6.55 
Dividend Yield2.19%
Market-to-Book Ratio1.71 
Price-to-Pre-Tax Profit PS11.90 
Price-to-Retained Profit PS20.19 
Price-to-Cash Flow PS10.58 
Price-to-Sales PS2.78 
Price-to-Net Tangible Asset Value PS-6.68 
Price-to-Cash PS84.29 
Net Working Capital PS2.24 
Price Pct to Working Capital PS20.45%
Earnings Yield6.93%
Average PE9.38 
Years in average5 
PE to PE average153.82%

Alliance Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio26.62%
Debt-to-Equity Ratio0.36 
Debt-to-Equity Ratio (excl. Intgbl)-1.42 
Debt-to-Equity Market Value0.21 
Net Gearing33.05%
Net Gearing (excl. Intangibles)187.72%
Gross Gearing34.38%
Gross Gearing (excl. Intangibles)195.27%
Gearing Under 1 Year10.58%
Gearing Under 1 Year (excl. Intgbl)60.10%
(Liquidity Ratios)
Net Working Capital to Total Assets5.48%
Current Ratio1.52 
Quick Ratio (Acid Test)1.00 
Liquidity Ratio0.13 
Cash & Equiv/Current Assets8.28%
(Solvency Ratios)
Enterprise Value145.11m
CFO/Attributable Profit1.36 
Total Debt/Equity Market Value0.31 
Total Debt/Sales0.85 
Total Debt/Pre-Tax Profit3.65 
Total Debt37.09m
Total Debt/Net Current Assets6.27%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth21.56%
Earn drops > 5% in 10yrs5 
Beta (60-Mnth)Beta (36-Mnth)
Alpha (60-Mnth)Alpha (36-Mnth)

Alliance Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)10.53%
Return On Assets (ROA)7.81%
Net Profit Margin19.26%
Assets Turnover0.41 
Return On Equity (ROE)11.85%
Return On Investment (ROI)8.90%
Dividend Payout Ratio31.55%
Plowback Ratio68.45%
Growth from Plowback Ratio8.48%
Net Income Of Revenues13.75%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.64 
Fixed Assets Turnover0.48 
Current Assets Turnover2.54 
Net Working Capital Turnover 
Inventory Turnover7.65 
(Other Operating Ratios)
Total Assets-to-Sales2.47 
Debt Collection Period86.01Days

Alliance Pharma Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
09 Sep 2015InterimGBX0.3612/31/201412/31/201512/17/201512/18/201501/14/2016-
25 Mar 2015FinalGBX0.6712/31/201312/31/201406/18/201506/19/201507/15/20151.00
10 Sep 2014InterimGBX0.3312/31/201312/31/201412/03/201412/05/201401/15/2015-
26 Mar 2014FinalGBX0.6112/31/201212/31/201306/11/201406/13/201407/10/20140.91
11 Sep 2013InterimGBX0.3012/31/201212/31/201312/04/201312/06/201301/15/2014-
21 Mar 2013FinalGBX0.5512/31/201112/31/201206/12/201306/14/201307/11/20130.83
12 Sep 2012InterimGBX0.2812/31/201112/31/201212/05/201212/07/201201/15/2013-
22 Mar 2012FinalGBX0.5012/31/201012/31/201106/13/201206/15/201207/12/20120.75
07 Sep 2011InterimGBX0.2512/31/201012/31/201111/30/201112/02/201101/13/2012-
23 Mar 2011FinalGBX0.4012/31/200912/31/201006/15/201106/17/201107/14/20110.57
08 Sep 2010InterimGBX0.1712/31/200912/31/201012/01/201012/03/201001/14/2011-
24 Mar 2010FinalGBX0.2312/31/200812/31/200906/16/201006/18/201007/15/20100.30
09 Sep 2009InterimGBX0.0712/30/200806/30/200912/02/200912/04/200901/15/2010-

Alliance Pharma Fundamentals

 31 Dec 2011 (GBP)31 Dec 2012 (GBP)31 Dec 2013 (GBP)31 Dec 2014 (GBP)
pre tax profit10.7123.31%10.8124.08%12.0126.39%10.1623.33%m
attributable profit8.6418.79%8.6919.36%9.5821.06%8.3919.26%m
retained profit7.2815.83%6.8915.34%7.5416.58%5.9913.75%m
eps - basic3.62 3.61 3.82 3.17 
eps - diluted3.39 3.40 3.68 3.16 
dividends per share0.75 0.83 0.91 1.00 

Alliance Pharma Balance Sheet

 31 Dec 2011 (GBP)31 Dec 2012 (GBP)31 Dec 2013 (GBP)31 Dec 2014 (GBP)
 31 Dec 2011 (GBP)31 Dec 2012 (GBP)31 Dec 2013 (GBP)31 Dec 2014 (GBP)
fixed assets fixed assets0.770.93%0.560.56%0.590.55%0.400.37%m
intangibles intangibles66.1380.37%79.8979.39%89.0683.24%88.8882.39%m
fixed investments fixed investments--%--%0.440.41%1.271.18%m
current assets - other current assets - other--%--%--%--%m
stocks stocks5.656.87%5.395.36%5.475.11%5.915.48%m
debtors debtors8.6610.52%10.1510.08%10.549.85%9.989.25%m
cash & securities cash & securities1.081.31%4.634.61%0.890.83%1.431.33%m
creditors - short creditors - short13.8616.84%22.0521.91%14.9513.97%11.4210.58%m
creditors - long creditors - long24.3029.53%26.7326.57%27.3725.59%25.6723.80%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves44.1353.63%51.8551.53%64.6760.44%70.7865.62%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Alliance Pharma Cash Flow Statement

31 Dec 2011 (GBP)31 Dec 2012 (GBP)31 Dec 2013 (GBP)31 Dec 2014 (GBP)
Operating CF10.1612.4410.0311.42m
Pre-Financing CF1.32-0.560.128.06m
Retained CF-0.883.53-5.802.43m

Alliance Pharma Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Numis Securities LimitedMarket Maker(MMF)Broker/DealerNUMSRAZHGB2LBIC
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us lse aph151126 19:39